+1 (904) 942-2327
$169.00 – $1,622.40Price range: $169.00 through $1,622.40
Semaglutide is a synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 receptor signaling pathways. This compound is intended strictly for experimental research applications and is not approved for human or veterinary use.
| Component | Description |
|---|---|
| Active Compound | Semaglutide (synthetic GLP-1 receptor agonist peptide) |
| Net Peptide Content | 15 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry where applicable |
Semaglutide is referenced in scientific literature for investigations into GLP-1 receptor binding kinetics, intracellular signaling cascades, and metabolic pathway modeling. All references to published studies are provided strictly for scientific background and experimental design purposes and are not intended as dosing or administration guidance.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Semaglutide is a synthetic peptide designed for laboratory research into GLP-1 receptor signaling pathways. This compound is supplied exclusively for in-vitro and experimental research applications and is not approved for human or veterinary use.
Semaglutide is widely referenced in scientific literature for its activity at glucagon-like peptide-1 (GLP-1) receptors, making it a valuable tool for researchers investigating receptor-ligand interactions, intracellular signaling cascades, and metabolic pathway dynamics in controlled laboratory environments.
Semaglutide may be used in experimental studies such as:
GLP-1 receptor binding affinity and kinetics
Intracellular signal transduction analysis
Secondary messenger and gene expression response modeling
Comparative peptide structureāactivity relationship studies
Stability, degradation, and formulation research
These investigations provide insights into incretin-related cellular mechanisms and support broader scientific understanding of peptide receptor pharmacology in controlled experimental systems.
For optimal stability, store under laboratory-appropriate cold conditions. Handle using standard laboratory peptide handling procedures. Proper reconstitution, aliquoting, and storage should follow institutional protocols.
This product is sold strictly for laboratory and research use. Not intended for:
Human consumption
Animal use
Diagnostic purposes
Therapeutic or clinical applications
No physiological, medical, or performance outcomes are implied or guaranteed. Researchers are responsible for ensuring compliance with institutional and regulatory requirements when working with investigational compounds.
Semaglutide is a synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 receptor signaling pathways. This compound is intended strictly for experimental research applications and is not approved for human or veterinary use.
| Component | Description |
|---|---|
| Active Compound | Semaglutide (synthetic GLP-1 receptor agonist peptide) |
| Net Peptide Content | 15 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry where applicable |
Semaglutide is referenced in scientific literature for investigations into GLP-1 receptor binding kinetics, intracellular signaling cascades, and metabolic pathway modeling. All references to published studies are provided strictly for scientific background and experimental design purposes and are not intended as dosing or administration guidance.
Semaglutide is a synthetic peptide designed for laboratory research into GLP-1 receptor signaling pathways. This compound is supplied exclusively for in-vitro and experimental research applications and is not approved for human or veterinary use.
Semaglutide is widely referenced in scientific literature for its activity at glucagon-like peptide-1 (GLP-1) receptors, making it a valuable tool for researchers investigating receptor-ligand interactions, intracellular signaling cascades, and metabolic pathway dynamics in controlled laboratory environments.
Semaglutide may be used in experimental studies such as:
GLP-1 receptor binding affinity and kinetics
Intracellular signal transduction analysis
Secondary messenger and gene expression response modeling
Comparative peptide structureāactivity relationship studies
Stability, degradation, and formulation research
These investigations provide insights into incretin-related cellular mechanisms and support broader scientific understanding of peptide receptor pharmacology in controlled experimental systems.
For optimal stability, store under laboratory-appropriate cold conditions. Handle using standard laboratory peptide handling procedures. Proper reconstitution, aliquoting, and storage should follow institutional protocols.
This product is sold strictly for laboratory and research use. Not intended for:
Human consumption
Animal use
Diagnostic purposes
Therapeutic or clinical applications
No physiological, medical, or performance outcomes are implied or guaranteed. Researchers are responsible for ensuring compliance with institutional and regulatory requirements when working with investigational compounds.
Semaglutide is a synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 receptor signaling pathways. This compound is intended strictly for experimental research applications and is not approved for human or veterinary use.
| Component | Description |
|---|---|
| Active Compound | Semaglutide (synthetic GLP-1 receptor agonist peptide) |
| Net Peptide Content | 15 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry where applicable |
Semaglutide is referenced in scientific literature for investigations into GLP-1 receptor binding kinetics, intracellular signaling cascades, and metabolic pathway modeling. All references to published studies are provided strictly for scientific background and experimental design purposes and are not intended as dosing or administration guidance.
WhatsApp us
Reviews
There are no reviews yet.